The Seal That Heals.
Convergent Medical is developing an ostomy appliance with negative pressure wound therapy built in, designed to prevent the leakage that damages the skin around a stoma.
Leakage is the main driver of skin damage around a stoma.
85%
develop peristomal skin complications in their first year
25%
lower mental well-being scores with frequent leakage
$2B
estimated annual U.S. healthcare cost
Peristomal skin complications — the skin damage that occurs around a stoma — are overwhelmingly caused by leakage from the ostomy appliance. This leakage exposes the skin to digestive output, causing pain, infection, and repeated hospitalizations. The burden falls on patients, caregivers, and the healthcare system alike.
How a stoma works — and why leakage matters.
How a stoma is created
A stoma is a surgically created opening in the abdomen that allows waste to exit the body when the normal digestive pathway is disrupted. It is typically created during surgery for colorectal cancer, Crohn's disease, ulcerative colitis, or traumatic injury. The stoma is a loop of intestine brought through the abdominal wall and sutured to the skin surface.
How the pouch goes on
An ostomy appliance — the pouch system — adheres to the skin around the stoma using a passive adhesive wafer. The barrier must form a tight seal against the skin to prevent digestive output from contacting the surrounding peristomal skin. Even small gaps or folds in the skin can allow output to undermine the seal and cause leakage.
What leakage does
When output leaks beneath the skin barrier, it exposes the peristomal skin to digestive enzymes and bacteria. This causes a cascade of skin breakdown: redness, erosion, ulceration, and infection. Damaged skin makes it harder to achieve a good seal on the next appliance change, creating a cycle of worsening complications, emergency visits, and diminished quality of life.
Negative pressure wound therapy, built into the ostomy appliance.
Convergent Medical's integrated prototype combines a standard ostomy pouch with a negative pressure wound therapy (NPWT) system. NPWT applies gentle suction at the skin-barrier interface, actively drawing the appliance against the skin. The result is a dynamic, self-correcting seal — not a passive adhesive.
Integrated prototype
Barrier, bag flange and valve in one base plate
Bench test results
Pressure film shows where the seal forms as air is removed
Built on proven technology
NPWT is a well-established wound care modality with decades of clinical evidence. Convergent Medical holds three issued U.S. patents covering the application of NPWT to ostomy appliances.
From formation to first commercial sale.
- Company formed at TMC Medical Device Labs
- Exclusive rights to three issued U.S. patents
- Prototype built and bench tested
- Backed by the TMC Venture Fund
- FDA Pre-Submission
- Feasibility study
- Target 510(k) clearance
- First commercial sale
Experienced founders. Clinical and operational depth.
David McDonough
Co-Founder and CEO
35+ years MedTech innovation, commercialization and leadership President of Northgate Technologies for 10 years. Grew revenue from $7M to $21M in 5 years with no outside capital. Six years at Hollister Inc.
Dr. Luis G. Fernandez
Co-Founder and CMO
Inaugural Endowed Chair in Trauma Surgery, University of Texas at Tyler School of Medicine Professor of Surgery, Division of Trauma Surgery and Surgical Critical Care, UT Health Science Center Tyler 25+ years of medical leadership across University of Texas hospitals
Deepak Prakash
Chief Operating Officer
Ran NPWT globally at Convatec, including its single-use NPWT system 11 years at Avery Dennison Medical in wound care and ostomy. Sr. Director of Marketing and Strategy; grew the core business at 3x the market Global New Product Development Manager, Hollister
Supported by Houston's premier medical innovation community.
TMC Medical Device Labs
Convergent Medical was formed at TMC Medical Device Labs, the Texas Medical Center's dedicated medical device incubator, providing access to world-class facilities, clinical expertise, and a network of healthcare innovators.
Texas Medical Center Venture Fund
The TMC Venture Fund backs early-stage medical technology companies emerging from the Texas Medical Center ecosystem, providing capital and strategic support to accelerate development and commercialization.
Partner with Convergent Medical.
We are actively engaging investors, clinical partners, and strategic collaborators as we advance our technology toward FDA clearance and first commercial sale.